Author

Kiara Vaden

Institution: Brigham Young University

Observed institutions: Brigham Young University, Brigham Young University - Idaho

OpenAlex ID: A5083752402

Adenoviral-delivered HE4-HSV-tk sensitizes ovarian cancer cells to ganciclovir.

2013 · Jennifer W Rawlinson, Kiara Vaden, et al. · PubMed · 9

Abstract 5619: Development of a TK1 specific chimeric antigen receptor T-cell for the treatment of non-small-cell lung cancer

2017 · Edwin J. Velazquez, Kiara Vaden, et al. · Cancer Research

Chimeric Antigen Receptor (CARs) for Thymidine Kinase 1 (TK1): A novel immunotherapy approach to fight cancer.

2017 · Edwin J. Velazquez, Kiara Vaden, et al.

Works count: 4

Citation count: 9

H-index: 1

I10-index: